{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,13]],"date-time":"2026-08-13T19:47:52Z","timestamp":1786650472702,"version":"build-2736575974"},"reference-count":7,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"6","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Indian J Pharmacol"],"published-print":{"date-parts":[[2013]]},"DOI":"10.4103\/0253-7613.121386","type":"journal-article","created":{"date-parts":[[2013,11,14]],"date-time":"2013-11-14T04:12:50Z","timestamp":1384402370000},"page":"634","source":"Crossref","is-referenced-by-count":5,"title":["A rare case of imatinib-induced erythroderma"],"prefix":"10.4103","volume":"45","author":[{"given":"Biju","family":"Vasudevan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rajesh","family":"Verma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vijendran","family":"Pragasam","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shekhar","family":"Neema","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"key-10.4103\/0253-7613.121386-1","doi-asserted-by":"crossref","unstructured":"Deininger MW, O\u2032Brien SG, Ford JM, Druker BJ. Practical management of patient with chronic myeloid leukemia receiving Imatinib. J Clin Oncol 21:1637-47.","DOI":"10.1200\/JCO.2003.11.143"},{"key":"key-10.4103\/0253-7613.121386-2","first-page":"228","volume-title":"Imatinib mesylate and dermatology part 2: A review of the cutaneous side effects of imatinib mesylate","author":"Scheinfeld","year":"2006","journal-title":"J Drugs Dermatol"},{"key":"key-10.4103\/0253-7613.121386-3","first-page":"1288","volume-title":"Imatinib induced Stevens - Johnson syndrome: Lack of recurrence following rechallenge with lower dose","author":"Pavithran","year":"2005","journal-title":"Indian J Dermatol Venereol Leprol","ISSN":"https:\/\/id.crossref.org\/issn\/0378-6323","issn-type":"print"},{"key":"key-10.4103\/0253-7613.121386-4","first-page":"207:329","volume-title":"Imatinib (STI-571)-induced exfoliative dermatitis in a Saudi patient with deck chair sign","author":"Banka","year":"2003","journal-title":"Dermatology"},{"key":"key-10.4103\/0253-7613.121386-5","first-page":"193","volume-title":"Imatinib induced erythroderma","author":"Mathew","year":"2007","journal-title":"Australas J Dermatol"},{"key":"key-10.4103\/0253-7613.121386-6","first-page":"538","volume-title":"Imatinib-induced erythroderma mediated by an unusual non-dose-dependent mechanism","author":"Vano-Galvan","year":"2007","journal-title":"Eur J Dermatol"},{"key":"key-10.4103\/0253-7613.121386-7","first-page":"1031","volume-title":"Efficacy and safety of a specific inhibitor of the BCR-ABL tyrosine kinase in chronic myeloid leukemia","author":"Druker","year":"2001","journal-title":"N Engl J Med"}],"container-title":["Indian Journal of Pharmacology"],"original-title":[],"language":"en","deposited":{"date-parts":[[2026,8,13]],"date-time":"2026-08-13T19:19:03Z","timestamp":1786648743000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/10.4103\/0253-7613.121386"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013]]},"references-count":7,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2013]]}},"alternative-id":["121386"],"URL":"https:\/\/doi.org\/10.4103\/0253-7613.121386","relation":{},"ISSN":["0253-7613"],"issn-type":[{"value":"0253-7613","type":"print"}],"subject":[],"published":{"date-parts":[[2013]]}}}